Order Revofil® Aquashine Soft Filler for Clinics

Revofil® Aquashine Soft Filler is a sterile, bioactive hyaluronic acid skin booster for mesotherapy and superficial dermal injection by trained professionals. Licensed clinics and healthcare professionals can order Revofil Aquashine Soft Filler 2 Pre-Filled Syringes for hydration-focused face, neck, and décolletage protocols. Each pack contains two ready-to-use 2 mL syringes with non-crosslinked hyaluronic acid at 15 mg/mL, supporting consistent treatment-room planning and traceable inventory control.

This product is intended for professional administration, not self-use. Clinics typically select it when the treatment goal is skin quality, hydration, elasticity, and surface refinement rather than structural contouring or high-projection volumization. US distribution helps aesthetic practices align purchasing with appointment schedules, lot records, and repeat skin-booster programs.

Price, Pack Format, and Clinic Ordering

Sign in with a verified professional account to view the current Revofil Aquashine Soft Filler price, case options, and volume terms. The two-syringe presentation helps clinics plan multi-area sessions or short series without opening additional packs, which can simplify treatment-room setup and intake documentation. Because contract pricing can vary by account and order quantity, the displayed cost should be reviewed at the time of purchase.

The pack presentation is Revofil® Aquashine Soft Filler- 2 Pre-Filled Syringes. Each syringe contains 2 mL of sterile solution. The formulation uses non-crosslinked hyaluronic acid at 15 mg/mL and includes a defined complex of peptides, vitamins, and amino acids. Labels show lot number and expiration date for receiving checks, chart documentation, and internal stock rotation.

Med Wholesale Supplies serves licensed clinics, med spas, and healthcare professionals with brand-name aesthetic medical products sourced through vetted distributors and verified supply channels. Product use should follow the manufacturer’s instructions, local professional standards, and the clinic’s established injection protocols. For broader product planning, clinics can browse related skin boosters, mesotherapy supplies, and dermal fillers.

What This Skin Booster Is and How It Works

Revofil Aquashine Soft Filler is a non-crosslinked hyaluronic acid preparation combined with selected bioactive ingredients. Hyaluronic acid is a naturally occurring glycosaminoglycan that binds water and contributes to skin hydration. In aesthetic practice, non-crosslinked HA skin boosters are used in superficial dermal workflows where hydration, elasticity, and surface texture are the main priorities.

The peptide, vitamin, and amino acid complex is designed for dermal revitalization protocols. This makes the product different from many contouring gels used to build projection in cheeks, lips, or jawline structures. As a Revofil Aquashine Soft dermal filler within a skin-booster workflow, it is better understood as a hydration and texture-support product than as a replacement for volumizing filler.

Clinics often position this product in biorevitalization programs, maintenance plans, or seasonal skin-refresh schedules. The ready-to-use syringe format supports controlled micro-deposition techniques, while the two-syringe pack gives staff flexibility for treating more than one area or managing a planned series. For a deeper discussion of the ingredient approach behind the brand, see how Revofil filler works.

Professional Applications and Treatment-Room Fit

Clinics integrate Aquashine Soft Filler 2 pre-filled syringes into mesotherapy and superficial dermal injection pathways for the face, neck, and décolletage. It fits protocols that focus on dullness, uneven surface quality, dehydration appearance, and reduced suppleness. Treatment plans should be determined by a qualified clinician after assessing skin quality, prior procedures, contraindications, and realistic goals.

The product’s main practical value is workflow consistency. Staff can stage a sealed, labeled syringe for a defined session, document the lot and expiry, and avoid drawing from a vial. The 2 mL syringe size also supports careful allocation across zones when a clinic uses small, evenly spaced deposits. Technique, injection depth, spacing, and total volume remain clinical decisions that should follow manufacturer guidance and the injector’s training.

Because this preparation is used superficially, many practices pair it with fine-needle or micro-depot methods depending on protocol. It may also be considered alongside device-assisted skin-booster procedures, provided the clinician confirms compatibility and sterility requirements. For clinics evaluating technique categories, the skin booster articles and dermal filler articles can support internal education and product positioning.

Key Features for Inventory and Protocol Planning

• Skin-booster class for superficial dermal placement by trained professionals.
• Two sterile, ready-to-use 2 mL pre-filled syringes per pack.
• Non-crosslinked hyaluronic acid concentration of 15 mg/mL.
• Bioactive complex containing peptides, vitamins, and amino acids.
• Hydration-focused positioning for skin quality and suppleness protocols.
• Mesotherapy-ready format for micro-depot workflows.
• Lot and expiration labeling to support traceability.
• Useful pack size for staged treatment plans and maintenance schedules.

Quick tip: Record lot number, expiry, treatment area, and syringe allocation at intake and immediately after administration.

Composition and Ingredient Context

The active component is non-crosslinked hyaluronic acid. The hyaluronic acid filler Aquashine Soft is supplied at 15 mg/mL and is combined with peptides, vitamins, and amino acids selected for skin revitalization workflows. Excipients are included for stability and isotonicity; clinics should refer to the manufacturer’s documentation for the complete ingredient list and handling instructions.

Non-crosslinked HA behaves differently from crosslinked volumizing gels. Crosslinking is commonly used to increase structure and persistence in contouring fillers, while non-crosslinked HA is generally used for hydration and superficial diffusion. That distinction matters when a clinic is choosing between a skin booster, a classic filler, or a more specialized Revofil presentation.

For brand-level evaluation, review the Revofil portfolio. Clinics comparing HA-based options across indications can also use hyaluronic acid in aesthetic medicine for background on why HA remains common in aesthetic injectables.

Handling, Storage, and Receiving Checks

On receipt, clinics should inspect the outer packaging, sterile seals, syringe appearance, lot number, and expiration date before placing the product into inventory. Do not use a syringe if packaging appears damaged, labeling is unclear, or the product appearance is inconsistent with manufacturer expectations. Store and handle the product according to the manufacturer’s instructions and your facility’s medical product procedures.

Temperature-controlled handling when required and tracked US delivery can help practices coordinate receiving responsibilities and inventory documentation. Assign trained staff to reconcile delivered quantities against the purchase record, document any variance promptly, and rotate stock so earlier expiration dates are used first. These steps support predictable treatment-room readiness and reduce avoidable waste.

Sterility should be maintained until use. Syringes are single-use medical products and should not be resterilized or shared between patients. Dispose of used needles, syringes, and contaminated materials in approved sharps or clinical waste containers according to facility policy.

Safety, Contraindications, and Professional Precautions

Revofil Aquashine Soft Filler should be administered only by licensed, trained professionals familiar with injection anatomy, aseptic technique, adverse-event recognition, and emergency response procedures. Before treatment, clinicians should evaluate medical history, allergies, active skin conditions, prior filler placement, medications that may affect bruising risk, and suitability for superficial dermal injection.

Expected injection-related effects can include temporary redness, tenderness, swelling, bruising, itching, or small bumps at treated sites. These effects are often procedure-related, but they still require appropriate counseling, documentation, and follow-up instructions. More serious complications may include infection, vascular compromise, hypersensitivity reactions, nodules, delayed inflammatory reactions, or tissue injury. Any concerning pain, discoloration, vision symptoms, spreading redness, fever, or progressive swelling requires prompt clinical assessment.

Do not inject into areas with active infection, inflamed skin, or compromised tissue unless a qualified clinician determines treatment is appropriate after resolution. Extra caution is warranted in patients with a history of severe allergies, autoimmune concerns, bleeding risk, or prior adverse reactions to injectables. Product selection and injection technique should be individualized by the treating professional, not based only on pack size or price.

Why it matters: Skin-booster placement is superficial, but vascular anatomy and sterile technique remain critical to patient safety.

Comparing Related Revofil and HA Options

Clinics choosing Revofil Aquashine Soft Filler 2 syringes should first define the protocol goal. Soft Filler is appropriate for hydration-focused and texture-oriented workflows. If the concern includes pigmentation-focused skin quality or a different Revofil formulation, clinics may evaluate Revofil Aquashine BR Soft Filler 2 pre-filled syringes or the single-syringe Revofil Aquashine BR Soft Filler 15 mg/mL format.

For practices that want a different Aquashine pathway, Revofil Aquashine PTX 2 pre-filled syringes may be reviewed as a related product within the same brand family. Teams that want to understand how product classes differ can use types of dermal fillers for selection considerations and Revofil versus Juvéderm for brand-positioning context.

Do not substitute products solely because they share a brand name or HA base. Formulation, rheology, intended placement, pack format, and clinic protocol may differ. Any substitution should be approved by the clinical lead and reflected in patient records, consent materials, and inventory documentation.

Ordering Workflow for Licensed Practices

Verified professional access is required to purchase through the wholesale channel. After account sign-in, your team can view current pricing, pack availability, and quantity options for the Revofil Aquashine Soft Filler presentation. Clinics purchasing for multiple locations should align quantities with scheduled procedures, injector preference, and storage capacity.

Before placing an order, confirm the exact product name, pack size, syringe quantity, concentration, and intended clinic protocol. After arrival, reconcile the delivered units against the purchase record and document lot and expiration details before the product enters treatment-room stock. These steps support repeatability across injectors and help keep charting consistent across staged programs.

For broader procurement planning, aesthetic practices can review wholesale dermal filler considerations. The article can help teams think through category breadth, supplier documentation, and practical stocking decisions without replacing manufacturer guidance or clinical training.

Authoritative Sources

• NIH: Hyaluronic Acid Overview
• Caregen Manufacturer Information

This content is for informational purposes only and is not a substitute for professional medical advice.